Fibrinolysis Before Cardiopulmonary Bypass?

Summary

It is common practice to use antifibrinolytic agents before and during cardiopulmonary bypass. They are not without side effects. The investigators want to show that there is no proof of fibrinolysis in standard sternotomy cardiac surgery patients before cardiopulmonary bypass, and that antifibrinolytic agents should only be started on cardiopulmonary bypass.

Timeline

Start

2013-07

Primary completion

2014-02

Completion

2014-02

Drugs

Indications